RITA THOMAS: Open Payments
NPI 1518190867 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,500 in 122 payments from 25 companies in 2025. Trend: 2023 $1,297 · 2024 $3,778 · 2025 $2,500
Food & beverage: $2,500
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $534 |
| Lilly USA, LLC | 18 | $315 |
| Novo Nordisk Inc | 9 | $224 |
| ABBVIE INC. | 24 | $205 |
| Otsuka America Pharmaceutical, Inc. | 8 | $168 |
| Corcept Therapeutics | 8 | $150 |
| ConvaTec Inc. | 4 | $119 |
| Phathom Pharmaceuticals, Inc. | 4 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Axsome Therapeutics, Inc. | 3 | $87 |
Products named: FARXIGA, VRAYLAR, REXULTI, Korlym, ZEPBOUND, MOUNJARO, INNOVAMATRIX AC, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
